FindTrial
Sign In

Development of an artificial intelligence system for ultrasound diagnosis of benign and malignant soft tissue masses and pathology of common soft tissue masses

Development of an artificial intelligence system for ultrasound diagnosis of benign and malignant soft tissue masses and pathology of common soft tissue masses

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104377
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue mass

Interventions

Gold Standard:The gold standard is the histopathological and immunohistochemical staining results of paraffin-embedded tumor tissue from the patients.
Index test:Ultrasound Diagnostic AI System

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Soft tissue masses diagnosed by ultrasound between 2019 and 2024. 2. Cases with confirmed pathological diagnosis.

Exclusion criteria

Exclusion criteria: 1. Patients whose ultrasound examination site does not match the site of pathological diagnosis. 2. Patients with inconclusive pathological results.

Design outcomes

Primary

MeasureTime frame
AUC;Accuracy;recall rate;—

Secondary

MeasureTime frame
Spearman's correlation coefficient;F1 score;—

Countries

China

Contacts

Public ContactLi Qiu

West China Hospital, Sichuan University

wsqiuli@126.com+86 189 8060 2044

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026